<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0370707</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3647</journal-id>
<journal-id journal-id-type="nlm-ta">Exp Eye Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Exp. Eye Res.</journal-id>
<journal-title-group>
<journal-title>Experimental eye research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0014-4835</issn>
<issn pub-type="epub">1096-0007</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30902621</article-id>
<article-id pub-id-type="pmc">6504593</article-id>
<article-id pub-id-type="doi">10.1016/j.exer.2019.03.008</article-id>
<article-id pub-id-type="manuscript">NIHMS1525497</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Phenotypes of Primary Retinal Macroglia: Implications for Purification and Culture Conditions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Backstrom</surname>
<given-names>Jon R.</given-names>
</name>
<!--<email>jon.backstrom@vumc.org</email>-->
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sheng</surname>
<given-names>Jinsong</given-names>
</name>
<!--<email>jinsong.sheng@vumc.org</email>-->
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fischer</surname>
<given-names>Rachel A.</given-names>
</name>
<!--<email>rachel.fischer@vanderbilt.edu</email>-->
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sappington</surname>
<given-names>Rebecca M.</given-names>
</name>
<!--<email>rebecca.m.sappington@vanderbilt.edu</email>-->
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rex</surname>
<given-names>Tonia S.</given-names>
</name>
<!--<email>tonia.rex@vanderbilt.edu</email>-->
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN 37232;</aff>
<aff id="A2"><label>2</label>Department of Ophthalmology &amp; Visual Sciences, Vanderbilt University School of Medicine, Nashville, TN 37232</aff>
<aff id="A3"><label>3</label>Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232</aff>
<author-notes>
<corresp id="CR1"><label>*</label>indicates Co-Corresponding authors</corresp>
<fn fn-type="con" id="FN1">
<p id="P31">Author Contributions</p>
<p id="P32">Conceptualization, TR and RMS; Methodology, RMS, JB, JS, RF; Validation, JB, JS; Formal Analysis, TR, RMS, JB; Investigation TR, RMS, JB; Resources, TR, RMS; Data Curation JB, JS; Writing – Original Draft Preparation, TR, RMS; Writing – Review &amp; Editing, TR, RMS, JB; Visualization, TR, JB, JS; Supervision, TR, RMS, JB; Project Administration, TR, RMS; Funding Acquisition, TR, RMS.</p>
</fn>
<fn fn-type="COI-statement" id="FN3">
<p id="P33">Conflicts of Interest</p>
<p id="P34">The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>27</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>5</month>
<year>2020</year>
</pub-date>
<volume>182</volume>
<fpage>85</fpage>
<lpage>92</lpage>
<!--elocation-id from pubmed: 10.1016/j.exer.2019.03.008-->
<abstract id="ABS1">
<p id="P1">Many neurodegenerations, including those of the visual system, have complex etiologies that include roles for both neurons and glia. In the retina there is evidence that retinal astrocytes play an important role in neurodegeneration. There are several approaches for isolating and growing primary retinal astrocytes, however, they often lead to different results. In this study, we examined the influence of culture conditions on phenotypic maturation of primary, purified retinal glia. We compared retinal astrocytes and Müller glia purified by immunomagnetic separation, as differentiation between these astrocyte subtypes is critical and immuno-based methods are the standard practice of purification. We found that while time in culture impacts the health and phenotype of both astrocytes and Müller glia, the phenotypic maturation of retinal astrocytes was most impacted by serum factors. These factors appeared to actively regulate intermediate filament phenotypes in a manner consistent with the induction of astrocyte-mesenchymal transition (AMT). This propensity for retinal astrocytes to shift along an AMT continuum should be considered when interpreting resulting data. Our goal is that this study will help standardize the field so that studies are replicable, comparable, and as accurate as possible for subsequent interpretation of findings.</p>
</abstract>
<kwd-group>
<kwd>astrocytes</kwd>
<kwd>Müller glia</kwd>
<kwd>retina</kwd>
<kwd>astrocyte-mesenchymal transition</kwd>
<kwd>primary culture</kwd>
<kwd>intermediate filaments</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>